A L Kung Selected Research

Multiple Myeloma

1/2014

CRM1 inhibition induces tumor cell cytotoxicity and impairs osteoclastogenesis in multiple myeloma: molecular mechanisms and therapeutic implications.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

A L Kung Research Topics

Disease

6	Leukemia 01/2016 - 01/2008
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2016 - 10/2012
3	Neoplasms (Cancer) 03/2012 - 09/2000
1	Plasma Cell Leukemia 01/2014
1	Multiple Myeloma 01/2014
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 05/2012
1	Genetic Translocation (Chromosomal Translocation) 01/2008
1	Hypoxia (Hypoxemia) 12/2000
1	Synovial Sarcoma (Synovioma) 09/2000
1	Virus Diseases (Viral Diseases) 04/2000

Drug/Important Bio-Agent (IBA)

3	Proteins (Proteins, Gene)FDA Link 01/2016 - 04/2013
3	Phosphotransferases (Kinase)IBA 05/2012 - 12/2010
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 10/2012 - 01/2008
2	nilotinib FDA Link 05/2012 - 12/2010
1	RNA (Ribonucleic Acid)IBA 01/2016
1	Bortezomib (Velcade)FDA Link 01/2014
1	guanosine 5'-monophosphorothioateIBA 04/2013
1	Exportin 1 ProteinIBA 01/2013
1	Tyrosine (L-Tyrosine)FDA Link 10/2012
1	plerixafor FDA Link 05/2012
1	LCL161IBA 12/2010
1	CREB-Binding ProteinIBA 12/2000
1	Oncogene Proteins (Oncogene Protein)IBA 09/2000
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2000
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 04/2000

Therapy/Procedure

3	Therapeutics 01/2013 - 12/2010
1	Combination Drug Therapy (Combination Chemotherapy) 01/2016
1	Drug Therapy (Chemotherapy) 04/2013
1	Transplantation 01/2008